Skip to main content
. 2018 Oct 30;9:4515. doi: 10.1038/s41467-018-06924-5

Fig. 2.

Fig. 2

SUMOylation of ROR-γt inhibits IL-17 expression. a Data show heatmap visualization of upregulated genes determined by RNA seq analysis in ROR-γt–/– CD4+ T cells transduced with either WT ROR-γt or K187R-ROR-γt and differentiated under Th17-inducing conditions. b Real-time PCR analysis was conducted for IL-17a mRNA expression in ROR-γt–/– CD4+ T cells transduced with either WT ROR-γt or K187R-ROR-γt. The relative fold change in the mRNA levels of the genes was normalized against ROR-γt–/– cells as compared with lentivirus-transduced ROR-γt–/– cells. c ELISA was conducted for IL-17A secretion in the culture supernatant of ROR-γt–/– cells transduced with lentivirus encoding V5-tagged WT-ROR-γt or K187R-ROR-γt. d Immunoblot analysis of the expression of lentiviral constructs of V5-ROR-γt in ROR-γt–/– cells. e Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of the IL-17-promoter-driven luciferase plasmid (pGL4-mIL17p) and plasmid-encoded HA-SUMO1, Myc-Ubc9, Flag-ROR-γt, and/or Flag-K187R-ROR-γt. f Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of plasmid pGL4-mIL17p along with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A. Results are presented in relative luciferase units (RLU). g Data show Ubc9 knockdown by Ubc9-specific shRNA (shUbc9) or control shRNA (shCtrl) in WT cLPLs that were stimulated with PMA and ionomycin. ELISA was performed to measure IL-17A secretion in culture supernatant of Ubc9 knockdown cLPLs as well as immunoblotting showing knockdown of Ubc9. h ELISA was performed to measure the IL-17A secretion in the culture supernatant of Ubc9 knockdown cells expressing either WT-ROR-γt or K187R-ROR-γt. i Real-time PCR analysis for IL-17a mRNA expression, in which the relative fold change in the mRNA levels of the genes has been normalized against ROR-γt-expressing cells treated with control shRNA compared to Ubc9-specific shRNA. j Immunoblot analysis shows Ubc9 knockdown in CD4+ T cells expressing either WT-ROR-γt or K187R-ROR-γt. Data are from one experiment representative of three independent experiments with similar results. *p< 0.05, **p< 0.01, ns: non-significant (two-tail t test) error bars are S.D.